Objective:

To assess the diagnostic performance of metagenomic and targeted next-generation sequencing (NGS) of bronchoalveolar lavage fluid in patients with suspected lower respiratory tract infections, and examine how sequencing results affected treatment.

Approach:

• Study design: Researchers at Chifeng Municipal Hospital retrospectively analyzed 941 patients tested between 2021 and 2023.
• Methods compared: Metagenomic NGS broadly screened for microbial DNA; targeted NGS tested for pathogens on a predefined panel. Results were compared with conventional microbiological testing.

Key Findings:

• Both NGS approaches had greater diagnostic yield than conventional microbiological testing. Reported sensitivity was 90.6% for metagenomic NGS and 73.4% for targeted NGS; the methods were assessed in separate patient groups.
• Targeted NGS identified 54 cases of Mycobacterium tuberculosis, including 42 missed by conventional testing, and detected Pneumocystis jirovecii in cases with negative routine silver staining.
• Among patients with positive targeted NGS results, 22.6% had antimicrobial therapy escalated after sequencing identified pathogens inadequately covered by initial treatment.
• Clinical improvement was reported in 66.2% of patients whose treatment was adjusted, compared with 66.7% of patients whose initial treatment was considered appropriate.
• Both sequencing approaches had low specificity, limiting their ability to distinguish infection-causing organisms from respiratory tract colonization.

Interpretation:

The study authors report that NGS may complement conventional microbiology in diagnosing complex respiratory infections and informing antimicrobial treatment. The study did not establish that sequencing-guided treatment caused the observed clinical outcomes.

Limitations:

• Retrospective, single-center study.
• The two sequencing approaches were not tested in the same patients.
• Differences in sequencing protocols complicated direct comparisons.
• Improvements could not be conclusively attributed to sequencing-guided treatment.

Conclusion:

The authors call for prospective studies to determine whether NGS diagnostic advantages translate into improved long-term patient outcomes.

Sources:

• Study published in Frontiers in Cellular and Infection Microbiology; article details not provided in the supplied context.